Search Results 211-220 of 13317 for monoclonal antibody

  1. Hematology - Clinical trials

    Mosunetuzumab is a monoclonal antibody that may interfere with the ability of cancer cells to grow and spread. ... antibodies and the factors that may ...

  2. Clinical trials - Oncology (Medical)

    Cetuximab is a monoclonal antibody that may interfere with the ability of tumor cells to grow and spread. Immunotherapy with monoclonal antibodies, such as ...

  3. Hematology - Clinical trials

    Inotuzumab ozogamicin is a monoclonal antibody, called inotuzumab, linked to a type of chemotherapy called calicheamicin. Inotuzumab attaches to cancer ...

  4. Eculizumab-aagh (intravenous route) - Side effects & uses - Mayo Clinic

    ... antibody positive. Eculizumab-aagh injection is a monoclonal antibody that works on the immune system. This medicine is available only under a restricted ...

  5. Adding The Immunotherapy Drug Cemiplimab To Usual Treatment For People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy And Immunotherapy (An Expanded Lung-MAP Treatment Trial) - Mayo Clinic

    Ramucirumab is a monoclonal antibody that may prevent the growth of new blood vessels that tumors need to grow. Adding cemiplimab to usual treatment, docetaxel ...

  6. Clinical trials - Oncology (Medical)

    Monoclonal antibodies, such as obinutuzumab, may interfere with the ability of cancer cells to grow and spread. It is not yet known whether giving ...

  7. A Study Of Copanlisib And Nivolumab In Treating Participants With Recurrent Or Refractory Diffuse Large B-cell Lymphoma Or Primary Mediastinal Large B-cell Lymphoma - Mayo Clinic

    Copanlisib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Monoclonal antibodies, such as nivolumab, may interfere ...

  8. Medical Research & Education - Mayo Clinic News Network

    Monoclonal antibodies: Update on this COVID-19 experimental therapy featured image. COVID-19. Monoclonal antibodies: Update on this COVID-19 experimental ...

  9. Medical Research & Education - Mayo Clinic News Network

    Monoclonal antibody treatment combo reduces hospitalization among high-risk patients with COVID-19 featured. Featured News. Monoclonal antibody treatment ...

  10. A Study of Idelalisib Combined with BI 836826 for Patients with Chronic Lymphocytic Leukemia - Mayo Clinic

    About this study. The purpose of this study is to evaluate the safety and tolerability of the combination of idelallisib with the monoclonal antibody BI ...